Status:

SUSPENDED

L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes

Lead Sponsor:

Samsung Medical Center

Collaborating Sponsors:

Jin Yang Pharmaceutical

Conditions:

Acute Myeloid Leukemia

Myelodysplastic Syndrome

Eligibility:

All Genders

Phase:

PHASE2

Brief Summary

To document therapeutic gain achieved by cyclic application of L-ascorbic acid (LAA) supplementation and depletion, while confirming safety and avoidance of clinically significant scurvy, in chemorefr...

Detailed Description

The seminal discovery that the in vitro growth of malignant cells could be absolutely dependent on L-ascorbic acid (LAA) was originally published in Sciene. The cell culture assay used with a mouse pl...

Eligibility Criteria

Inclusion

  • Patients should have AML or MDS according to new WHO classification, with minimum of 5% blasts in peripheral blood.
  • There must be a clear and acceptable reason for not receiving standard treatments (chemotherapy and/or stem cell transplantation); or standard treatments have already been given and this option exhausted with evidence of refractory disease.
  • Prior treatments of any forms are allowed provided there is no potential residual beneficial effect and the patients are off treatment for at least 4 weeks, with estimated life expectancy of at least 2 months.
  • Adequate amount (4 ml) of bone marrow sent to the laboratory for cell culture studies.
  • There are no restrictions based on age, sex, or ethnicity except that adequate contraception must be practiced in women of childbearing ages. Although AML is rare in children, pediatric patients will be accepted.
  • There is no deficiency of G6PD (RBC).
  • Asymptomatic patients with disease progression and symptomatic patients.

Exclusion

  • \-

Key Trial Info

Start Date :

May 1 1998

Trial Type :

INTERVENTIONAL

End Date :

August 1 2005

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00329498

Start Date

May 1 1998

End Date

August 1 2005

Last Update

October 26 2006

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Samsung Medical Center

Seoul, South Korea

L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes | DecenTrialz